Open access
Open access
Powered by Google Translator Translator

Geriatrics

CDC Study: Suspected SARS-CoV-2 reinfections in a skilled nursing facility

28 Feb, 2021 | 21:55h | UTC

Suspected Recurrent SARS-CoV-2 Infections Among Residents of a Skilled Nursing Facility During a Second COVID-19 Outbreak — Kentucky, July–November 2020 – CDC Morbidity and Mortality Weekly Report

Commentaries: Possible SARS-CoV-2 Reinfection Described at Skilled Nursing Facility – HealthDay AND Reinfections could be more likely among those with a mild first case of COVID-19: case study – CTV News

 

Commentary on Twitter (thread – Click for more)

 


WHO Report: Preparing for Long COVID 2021

26 Feb, 2021 | 08:46h | UTC

In the wake of the pandemic: preparing for Long COVID (2021) – World Health Organization

News release: New policy brief calls on decision-makers to support patients as 1 in 10 report symptoms of “long COVID” – World Health Organization

Commentaries: Long COVID sufferer still has disease’s debilitating symptoms nearly a year after first falling ill – EuroNews AND Debilitating ‘long-COVID’ may have severe health, social impacts: WHO – Reuters

Related: Dr. Fauci says new data suggests ‘long’ Covid symptoms can last up to 9 months – CNBC

 


RCT: Effect of telephone cognitive behavioral therapy for insomnia in older adults with osteoarthritis pain

25 Feb, 2021 | 08:29h | UTC

Effect of Telephone Cognitive Behavioral Therapy for Insomnia in Older Adults With Osteoarthritis Pain: A Randomized Clinical Trial – JAMA Internal Medicine

Commentary: Effective treatment for insomnia delivered in a few short phone calls – University of Washington

 


Medication review interventions to reduce hospital readmissions in older people

24 Feb, 2021 | 02:14h | UTC

Medication review interventions to reduce hospital readmissions in older people – Journal of the American Geriatrics Society

 

Commentary on Twitter

 


State of the Art Review: Vaccines for older adults

23 Feb, 2021 | 01:23h | UTC

Vaccines for older adults – The BMJ (free for a limited period)

 


Long Covid: Sequelae in adults at 6 Months after COVID-19 infection

21 Feb, 2021 | 22:13h | UTC

Sequelae in Adults at 6 Months After COVID-19 Infection – JAMA Network Open

Commentaries: Almost a third of people with ‘mild’ COVID-19 still battle symptoms months later, study finds – CNN AND Nearly One Third of Covid-19 Survivors Have Symptoms, Some Up To 9 Months Later, New Study Finds – Forbes

 

Commentary on Twitter

 


Study: In intensively treated hypertensive patients, a diastolic blood pressure of less than 60 mm Hg was associated with increased risk of cardiovascular events

19 Feb, 2021 | 02:37h | UTC

Evaluation of Optimal Diastolic Blood Pressure Range Among Adults With Treated Systolic Blood Pressure Less Than 130 mm Hg – JAMA Network Open

Commentary: Treated Diastolic Blood Pressure: How Low Is Too Low? – NEJM Journal Watch

 

Commentary on Twitter

 


M-A: Intra-articular saline injection is as effective as corticosteroids, platelet-rich plasma, and hyaluronic acid for hip osteoarthritis pain

19 Feb, 2021 | 02:35h | UTC

Intra-articular saline injection is as effective as corticosteroids, platelet-rich plasma and hyaluronic acid for hip osteoarthritis pain: a systematic review and network meta-analysis of randomised controlled trials – British Journal of Sports Medicine

 

Commentary on Twitter

 


How many people get ‘long COVID’ – and who is most at risk?

19 Feb, 2021 | 02:54h | UTC

How many people get ‘long COVID’ – and who is most at risk? – The Conversation

 


SR: Integrating palliative care in ambulatory care of noncancer serious chronic illness

19 Feb, 2021 | 02:28h | UTC

Integrating Palliative Care in Ambulatory Care of Noncancer Serious Chronic Illness: A Systematic Review – Agency for Healthcare Research and Quality

Full report: Integrating Palliative Care in Ambulatory Care of Noncancer Serious Chronic Illness

Evidence summary: Integrating Palliative Care in Ambulatory Care of Noncancer Serious Illness

 


RCT: Levothyroxine does not reduce the risk of developing depressive symptoms in older adults with subclinical hypothyroidism

18 Feb, 2021 | 02:46h | UTC

Effect of Levothyroxine Therapy on the Development of Depressive Symptoms in Older Adults With Subclinical Hypothyroidism: An Ancillary Study of a Randomized Clinical Trial – JAMA Network Open

Related Studies: Association Between Levothyroxine Treatment and Thyroid-Related Symptoms Among Adults Aged 80 Years and Older With Subclinical Hypothyroidism – JAMA AND Thyroid Hormone Therapy for Older Adults with Subclinical Hypothyroidism – New England Journal of Medicine AND L-Thyroxine Therapy for Older Adults With Subclinical Hypothyroidism and Hypothyroid Symptoms: Secondary Analysis of a Randomized Trial – Annals of Internal Medicine

Guidelines (conflicting viewpoints): BMJ Guideline: Treatment of Subclinical Hypothyroidism AND Society for Endocrinology & British Thyroid Association issue statement against new treatment recommendations for subclinical hypothyroidism

 

Commentary on Twitter

 


M-A: Preventable medication harm across health care settings

18 Feb, 2021 | 02:43h | UTC

Preventable medication harm across health care settings: a systematic review and meta-analysis – BMC Medicine

Commentary: Preventable medication harm across health care settings: a systematic review and meta-analysis – PSNet

 


RCT: Among patients with knee osteoarthritis, high-intensity strength training was not associated with better outcomes compared with low-intensity strength training or an attention control

17 Feb, 2021 | 01:24h | UTC

Effect of High-Intensity Strength Training on Knee Pain and Knee Joint Compressive Forces Among Adults With Knee Osteoarthritis: The START Randomized Clinical Trial – JAMA

Commentary: No Benefit from High-Intensity Strength Training for Knee Osteoarthritis – NEJM Journal Watch

 

Commentary on Twitter

 


Cohort study: Risk factors associated with transition from acute to chronic low back pain

17 Feb, 2021 | 01:21h | UTC

Risk Factors Associated With Transition From Acute to Chronic Low Back Pain in US Patients Seeking Primary Care – JAMA Network Open

 

Commentary on Twitter

 


SR: Interventions for improving outcomes in patients with multimorbidity in primary care and community settings

17 Feb, 2021 | 01:11h | UTC

Interventions for improving outcomes in patients with multimorbidity in primary care and community settings – Cochrane Library

Summary: Improving outcomes for people with multiple chronic conditions – Cochrane Library

 


Review: Diagnosis and treatment of hip and knee osteoarthritis

16 Feb, 2021 | 02:05h | UTC

Diagnosis and Treatment of Hip and Knee Osteoarthritis: A Review – JAMA (free or a limited period)

 


Effectiveness of telerehabilitation in physical therapy: A rapid overview

16 Feb, 2021 | 01:53h | UTC

Effectiveness of telerehabilitation in physical therapy: A rapid overview – Physical Therapy

 


M-A: No link between blood pressure drugs and falls

12 Feb, 2021 | 02:05h | UTC

No link between blood pressure drugs and falls, finds study – University of Oxford

Original study: Association between antihypertensive treatment and adverse events: systematic review and meta-analysis – The BMJ

 

Commentary on Twitter (thread – click for more)

 


SR: Plasma and cerebrospinal fluid ABeta42 for the differential diagnosis of Alzheimer’s disease dementia

12 Feb, 2021 | 01:53h | UTC

Plasma and cerebrospinal fluid ABeta42 for the differential diagnosis of Alzheimer’s disease dementia in participants diagnosed with any dementia subtype in a specialist care setting – Cochrane Library

 


RCT: The effect of daily protein supplementation, with or without resistance training for 1 year, on muscle size, strength, and function in healthy older adults

11 Feb, 2021 | 01:58h | UTC

The effect of daily protein supplementation, with or without resistance training for 1 year, on muscle size, strength, and function in healthy older adults: A randomized controlled trial – The American Journal of Clinical Nutrition (link to abstract – $ for full-text)

 

Commentary on Twitter

 


WHO experts recommend AstraZeneca COVID vaccine across all ages and countries

11 Feb, 2021 | 02:20h | UTC

WHO Report: Interim recommendations for use of the AZD1222 (ChAdOx1-S [recombinant]) vaccine against COVID-19 developed by Oxford University and AstraZeneca – World Health Organization

Commentaries: WHO Experts Recommend AstraZeneca COVID Vaccine Across All Ages & Countries – Signal For Start Of Global COVAX Vaccine Rollout – Health Policy Watch AND WHO backs use of Oxford/AstraZeneca Covid vaccine for adults of all ages – The Guardian AND Covid: WHO backs Oxford vaccine ‘even if variants present’ – BBC AND Expert reaction to WHO recommending use of the Oxford/AstraZeneca COVID-19 vaccine, including in over 65s – Science Media Centre AND Up Against Mutants, WHO Says AstraZeneca Vaccine Is Still A Good Bet – NPR

 


Cohort study: Low risk of progression to diabetes among older adults with “prediabetes”

9 Feb, 2021 | 01:09h | UTC

Risk of Progression to Diabetes Among Older Adults With Prediabetes – JAMA Internal Medicine (free for a limited period)

Commentaries: “Prediabetes” Diagnosis Less Useful in Older Patients – Johns Hopkins Bloomberg School of Public Health AND Prediabetes—A Risk Factor Twice Removed – JAMA Internal Medicine (free for a limited period) AND How many pre-diabetics go on to develop diabetes? – MedicalResearch.com

Author Interview: Risk of Progression to Diabetes Among Older Adults With Prediabetes

Related: The war on ‘prediabetes’ could be a boon for pharma—but is it good medicine? – Science

 


Canadians Win Again – Syncope Score Systematic Review

9 Feb, 2021 | 01:03h | UTC

Canadians Win Again – Syncope Score Systematic Review – Journal Feed

Original study: Multivariable risk scores for predicting short‐term outcomes for emergency department patients with unexplained syncope: A systematic review – Academic Emergency Medicine

See calculator: Canadian Syncope Risk Score – MdCalc

 


Review: Dysphagia in older adults

5 Feb, 2021 | 01:22h | UTC

Dysphagia in Older Adults – Mayo Clinic Proceedings

 


The AstraZeneca vaccine and over-65s: we may not have all the data yet, but limiting access could be counterproductive

3 Feb, 2021 | 01:46h | UTC

The AstraZeneca vaccine and over-65s: we may not have all the data yet, but limiting access could be counterproductive – The Conversation

 


Stay Updated in Your Specialty

No spam, just news.